1-Cho NH, Shaw JE, Karuranga S, Huang Y, Huang Y, da Rocha Fernandes JD, Ohlrogge AW et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-281.
2-Unnikrishnan R, Misra A. Infections and diabetes: Risks and mitigation with reference to India. Diabetes Metab Syndr. 2020;14(6):1889-1894.
3-Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. 2012;16 Suppl 1:S27-36.
4-Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study. Diabetes Care. 2018;41(10):2127-2135.
5-Mor A, Dekkers OM, Nielsen JS, eck-Nielsen H, Sørensen HT, Thomsen RW. Impact of Glycemic Control on Risk of Infections in Patients With Type 2 Diabetes: A Population-Based Cohort Study. Am J Epidemiol. 2017;186(2):227-236.
6-Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J. Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol. 2016;4(2):148-158.
7-Diabetes Canada Clinical Practice Guidelines Expert C, Punthakee Z, Goldenberg R, et al. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes. 2018;42 Suppl 1:S10-S15.
8-Hu ZD, Gu B. Laboratory diagnosis of infectious diseases: a call for more rapid and accurate methods. Ann Transl Med. 2020;8(9):600.
9-Ady J, Fong Y. Imaging for infection: from visualization of inflammation to visualization of microbes. Surg Infect (Larchmt). 2014;15(6):700-707.
10-Washington JA. Principles of Diagnosis. In: th, Baron S, editors. Medical Microbiology. Galveston (TX)1996.
11-Chen S, Shen Y, Liu YH, Dai Y, Wu ZM, Wang XQ et al. Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021; 20(1):64.
12-Akash MSH, Rehman K, Fiayyaz F, Sabir S, Khurshid M.Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies. Arch Microbiol. 2020;202(5):953-965.
13-Hua J, Huang P, Liao H, Lai X, Zheng X.Prevalence and Clinical Significance of Occult Pulmonary Infection in Elderly Patients with Type 2 Diabetes Mellitus. Biomed Res Int. 2021;2021:3187388.
14-Liu K, Lee GC. Healthcare utilisation and cost expenditures for pneumonia in individuals with diabetes mellitus in the USA. Epidemiol Infect. 2019;147:e212.
15-Yenehun Worku G, Belete Alamneh Y, Erku Abegaz W. Prevalence of Bacterial Urinary Tract Infection and Antimicrobial Susceptibility Patterns Among Diabetes Mellitus Patients Attending Zewditu Memorial Hospital, Addis Ababa, Ethiopia. Infect Drug Resist. 2021;14:1441-1454.
16-Zubair KU, Shah AH, Fawwad A, Sabir R, Butt A.Frequency of urinary tract infection and antibiotic sensitivity of uropathogens in patients with diabetes. Pak J Med Sci. 2019;35(6):1664-1668.
17-Yong PH, Weinberg L, Torkamani N, Churilov L, Robbins RJ, Ma R et al. The Presence of Diabetes and Higher HbA1c Are Independently Associated With Adverse Outcomes After Surgery. Diabetes Care. 2018; 41(6):1172-1179.
18-Ross MN, Iyer S, Gundle KR, Ross DA.Association of Preoperative Hemoglobin A1c and Body Mass Index with Wound Infection Rate in Spinal Surgery. Int J Spine Surg. 2021;15(4):811-817.
19-Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589.
20-Hamilton EJ, Martin N, Makepeace A, Sillars BA, Davis WA, Davis TM.Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the fremantle diabetes study. PLoS One. 2013;8(3):e60502.
21-Ikeda A, Ikeda K, Takai A, Takahashi K, Ueda Y, Marusawa H, Takahashi K, Ueda Y, Marusawa H et al. Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c. Digestion. 2017;96(4):228-230.
22-Chang CH, Wang JL, Wu LC, Chuang LM, Lin HH.Diabetes, Glycemic Control, and Risk of Infection Morbidity and Mortality: A Cohort Study. Open Forum Infect Dis. 2019;6(10):ofz358.
23-Zoppini G, Fedeli U, Schievano E, Dauriz M, Targher G, Bonora E et al. Mortality from infectious diseases in diabetes. Nutr Metab Cardiovasc Dis. 2018;28(5):444-450.
24-Shang L, Shao M, Guo Q, Shi J, Zhao Y, Xiaokereti J et al. Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis. Arch Med Res. 2020; 51(7):700-709.
25-Toniolo A, Cassani G, Puggioni A, Rossi A, Colombo A, Onodera T et al. The diabetes pandemic and associated infections: suggestions for clinical microbiology. Rev Med Microbiol. 2019; 30(1):1-17.
26-Pal R, Banerjee M. Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19? Prim Care Diabetes. 2021;15(1):18-20.
27-Erener S. Diabetes, infection risk and COVID-19. Mol Metab. 2020; 39:101044.
28-Costantini E, Carlin M, Porta M, Brizzi MF.Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence. Acta Diabetol. 2021; 58(9):1139-1151.
29-Chang CW, Kok VC, Tseng TC, Horng JT, Liu CE. Diabetic patients with severe sepsis admitted to intensive care unit do not fare worse than non-diabetic patients: a nationwide population-based cohort study. PLoS One. 2012;7(12):e50729.
30-Comino EJ, Harris MF, Islam MD, Tran DT, Jalaludin B, Jorm L et al. Impact of diabetes on hospital admission and length of stay among a general population aged 45 year or more: a record linkage study. BMC Health Serv Res. 2015;15:12.
31-Wang J, Luo X, Jin X, Lv M, Li X, Dou J et al. Effects of Preoperative HbA1c Levels on the Postoperative Outcomes of Coronary Artery Disease Surgical Treatment in Patients with Diabetes Mellitus and Nondiabetic Patients: A Systematic Review and Meta-Analysis. J Diabetes Res. 2020; 2020:3547491.